FDA Aggressively Looking for Data Integrity Problems in Inspections
This article was originally published in The Gold Sheet
Executive Summary
FDA inspectors using a new forensic approach to inspections in responding to a rash of data integrity problems found in pharmaceutical manufacturing facilities. Attorneys advise firms to pay careful attention to their adverse event reports and field alert reports as data integrity breaches can be found there too.